Responses
Poster
IGCS20_1171
180 An open-label randomized active-controlled phase ii clinical study to assess efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.